BNB Treasury Strategy Backfires as Nasdaq Delists Windtree Therapeutics

TLDR Nasdaq will delist Windtree Therapeutics after it failed to meet compliance requirements. The company confirmed the decision through an SEC filing signed by Chief Executive Jed Latkin. Windtree shares dropped by more than 76% in one day following the delisting notice. The stock has lost over 90 percent in one month and more than [...]

The post BNB Treasury Strategy Backfires as Nasdaq Delists Windtree Therapeutics appeared first on Blockonomi.